Prot# X05268// NU 08C5: A Phase II Trial Evaluating the Effects of Bortezomib in Patients with Recurrent Malignant Gliomas Treated Prior to Surgery and Then Bortezomib and Temozolomide Post-Operatively

Project: Research project

Project Details

StatusFinished
Effective start/end date3/27/097/23/18

Funding

  • Millennium Pharmaceuticals, Inc (X05268//NU 08C5)